CompoAtlas

Cal Apatite 1000

Natural health product licensed in Canada

Other names
Cal Apatite Bone Builder Extra Strength
Licence holder
Metagenics Inc.
NPN or DIN-HM
80070349
Status
Inactive licence
Licence date
14 June 2016
Revision date
Not provided
Form
Comprimé
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Calcium

Source : Durapatite

337 milligramme1,011,000 µg
Calcium

Source : Phosphate de calcium, dibasique

337 milligramme1,011,000 µg

Non-medicinal ingredients

NA, Acide stéarique, Cellulose, Hypromellose, Dioxyde de silicium, Croscarmellose de sodium, Hydroxypropylcellulose

PopulationAgeQuantity per servingFrequency
AdultesNot specified3 Comprimé1 day

Uses authorised in Canada

Adequate calcium as part of a healthy diet, may help prevent bone loss/osteoporosis. Helps in the development and maintenance of bones and teeth. Adequate calcium as part of a healthy diet may reduce the risk of developing osteoporosis. Helps to maintain the body's ability to metabolize nutrients.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Source

Official Health Canada record, licence 80070349

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line